Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards

Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials

(2022) Kevin Kunzmann et al.   STATISTICS IN MEDICINE

Some design considerations incorporating early futility for single‐arm clinical trials with time‐to‐event primary endpoints using Weibull distribution

(2021) Muhammad Waleed et al.   PHARMACEUTICAL STATISTICS

Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions

(2021) Milind A. Phadnis et al.   BIOMETRICAL JOURNAL

Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice

(2019) Kim Jachno et al.   BMC Medical Research Methodology

Group sequential design for time-to-event data using the concept of proportional time

(2019) Milind A Phadnis et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects

(2018) José L. Jiménez et al.   PHARMACEUTICAL STATISTICS

On the Conditional Power in Survival Time Analysis Considering Cure Fractions

(2017) Andreas Kuehnapfel et al.  

A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution

(2017) Milind A. Phadnis et al.   STATISTICS IN MEDICINE

Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated

(2016) Patrick Royston et al.   BMC Medical Research Methodology

Simulating survival data with predefined censoring rates for proportional hazards models

(2016) Fei Wan   STATISTICS IN MEDICINE

Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials

(2016) Dominic Magirr et al.   PLoS One

Design of clinical trials with failure-time endpoints and interim analyses: An update after fifteen years

(2015) Pei He et al.   Contemporary Clinical Trials

Power and Sample Size for Randomized Phase III Survival Trials Under the Weibull Model

(2015) Jianrong Wu   Journal of Biopharmaceutical Statistics

Group Sequential Design for Randomized Phase III Trials under the Weibull Model

(2014) Jianrong Wu et al.   Journal of Biopharmaceutical Statistics

An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect

(2014) Patrick Royston et al.   Trials

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit

(2011) Patrick Royston et al.   Trials

A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials

(2009) Ricardo M Fernandes et al.   BMC Pediatrics

A Conditional Power Approach to the Evaluation of Predictive Power

(2009) K.K. Gordon Lan et al.   Statistics in Biopharmaceutical Research

The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias

(2008) Puvan Tharmanathan et al.   BMC Medical Research Methodology